|
|
| Cell line |
Description of cell line |
Original reference |
Origin |
Sex |
Age |
Source |
| HEL |
Erythroleukemia cell line (AML M6 in relapse after treatment for Hodgkin's disease) |
Martin et al., Science 216: 1233 (1982) |
peripheral blood |
M |
30 |
DSMZ |
| HL-60 |
Acute promyelocytic leukemia (APL) cell line |
Collins et al., Nature 270: 347-349 (1977) |
peripheral blood |
F |
35 |
DSMZ |
| HMC-1 |
Mastcell leukemia cell line |
Butterfield et al., Leukemia Res. 12: 345-355 (1988) |
peripheral blood |
M |
52 |
KN1 |
| K-562 |
Chronic myeloid leukemia (CML) cell line |
Lozzio et al., J Natl Cancer Inst 50: 535 (1973) |
pleural effusion |
F |
53 |
DSMZ |
| NB-4 |
Acute promyelocytic leukemia (APL) cell line |
Lanotte et al., Blood 77: 1080 (1991) |
bone marrow |
F |
23 |
DSMZ |
| THP-1 |
Acute monocytic leukemia (AML) cell line |
Tsuchiya et al., Int J Cancer 26: 171 (1980) |
peripheral blood |
M |
1 |
DSMZ |
| U-937 |
Myelomonocytic histiocytic lymphoma cell line |
Sundström C, Nilsson K., Int J Cancer 17:565-577 (1976) |
pleural effusion |
M |
37 |
KN1 |
|
|
| Cell line |
Description of cell line |
Original reference |
Origin |
Sex |
Age |
Source |
| Daudi |
Human Burkitt lymphoma cell line |
Klein et al., Cancer Res 28: 1300 (1968) |
orbital biopsy |
M |
16 |
DSMZ |
| HDLM-2 |
Hodgkin lymphoma cell line |
Drexler et al., Leuk Res 10: 487 (1986) |
pleural effusion |
M |
74 |
DSMZ |
| Karpas-707 |
Multiple myeloma cell line |
Karpas et al., Lancet Apr 24;1(8278): 931-3 (1982) |
bone marrow and peripheral blood |
M |
53 |
KN1 |
| KM3 |
B-cell leukemia cell line (ALL, second relapse) |
Schneider et al., Int J Cancer 19: 621-626 (1977) |
peripheral blood |
M |
12 |
DSMZ* |
| LP-1 |
Multiple myeloma cell line |
Pegoraro et al., Blood 73: 1020 (1989) |
peripheral blood |
F |
56 |
DSMZ |
| MOLT-4 |
Acute lymphoblastic leukemia (T-ALL) cell line |
Minowada et al., J Natl Cancer Inst 49: 891 (1972) |
peripheral blood |
M |
19 |
DSMZ |
| RPMI-8226 |
Multiple myeloma cell line |
Matsuoka et al., Proc Soc Exp Biol Med 125: 1246 (1967) |
peripheral blood |
M |
61 |
DSMZ |
| U-266/70 |
Multiple myeloma cell line (1970, IL-6-dependent) |
Nilsson et al Clin Exp Immunol 7:477-489 (1970) |
peripheral blood |
M |
53 |
KN1 |
| U-266/84 |
Multiple myeloma cell line (1984, in vitro differentiated) |
Hellman et al., Eur J Immunol 18:905-910 (1988) |
peripheral blood |
M |
53 |
KN1 |
| U-698 |
B-cell lymphoma cell line (lymphoblastic lymphosarcoma) |
Nilsson et al., Int J Cancer 13: 808-823 (1974) |
tonsil |
M |
7 |
DSMZ |
|
|
| Cell line |
Description of cell line |
Original reference |
Origin |
Sex |
Age |
Source |
| D341 Med |
Medulloblastoma cell line |
Friedman et al. Am. J. Pathol. 130: 472 (1988) |
brain |
M |
3 |
LGC/ATCC |
| SH-SY5Y |
Metastatic neuroblastoma, clonal subline of neuroepithelioma cell line SK-N-SH |
Biedler et al., Cancer Res 33: 2643 (1973) |
bone marrow |
F |
4 |
DSMZ |
| U-138MG |
Glioblastoma cell line |
Ponten et al., Acta Pathol Microbiol Scand 74: 465 (1968) |
brain |
M |
47 |
DSMZ |
| U-251MG |
Glioblastoma cell line |
Westermark B., Int J Cancer12: 438 (1973) |
brain |
M |
0 |
BW2 |
| U-87MG |
Glioblastoma, astrocytoma cell line |
** |
brain |
F |
44 |
LGC/ATCC |
|
|
| Cell line |
Description of cell line |
Original reference |
Origin |
Sex |
Age |
Source |
| A-549 |
Lung carcinoma cell line |
Giard et al., J Natl Cancer Inst 51: 1417 (1973) |
lung |
M |
58 |
DSMZ |
| SCLC-21H |
Small cell lung carcinoma cell line |
Bepler et al., J Cancer Res Clin Oncol 113: 31 (1987) |
pleural effusion |
M |
46 |
DSMZ |
|
|
| Cell line |
Description of cell line |
Original reference |
Origin |
Sex |
Age |
Source |
| CACO-2 |
Colon adenocarcinoma cell line |
Fogh J., et al. J. Natl. Cancer Inst. 58: 209 (1977) |
colon |
M |
72 |
DSMZ |
| CAPAN-2 |
Pancreas adenocarcinoma cell line |
Kyriazis et al., Cancer Res 46: 5810 (1986) |
pancreas |
M |
56 |
DSMZ |
| Hep-G2 |
Hepatocellular carcinoma cell line |
Aden et al., Nature 282: 615 (1979) |
liver |
M |
15 |
DSMZ |
|
|
| Cell line |
Description of cell line |
Original reference |
Origin |
Sex |
Age |
Source |
| AN3-CA |
Metastatic endometrial adenocarcinoma cell line |
Dawe et al., J Natl Cancer Inst 33: 441 (1964) |
lymph node |
F |
55 |
DSMZ |
| EFO-21 |
Metastatic ovarian serous cystadenocarcinoma cell line |
Simon et al., J Natl Cancer Inst 70: 839 (1983) |
ascites |
F |
56 |
DSMZ |
| HeLa |
Cervical epithelial adenocarcinoma cell line |
Scherer et al., J Exp Med 97: 695 (1953) |
cervix |
F |
31 |
DSMZ |
| MCF-7 |
Metastatic breast adenocarcinoma cell line |
Soule et al., J Natl Cancer Inst 51: 1409 (1973) |
pleural effusion |
F |
69 |
DSMZ |
| SiHa |
Cervical squamous cell carcinoma cell line, integrated 1-2 copies of HPV16 |
Friedl F. et al.Proc., Soc. Exp. Biol. Med. 135: 543-545 (1970) |
cervix |
F |
55 |
LGC/ATCC |
| SK-BR-3 |
Metastatic breast adenocarcinoma cell line |
Fogh J, editor. Human tumor cells in vitro. New York: Plenum Press (1975) |
pleural effusion |
F |
43 |
LGC/ATCC |
|
|
| Cell line |
Description of cell line |
Original reference |
Origin |
Sex |
Age |
Source |
| NTERA-2 |
Metastatic embryonal carcinoma cell line, cloned from TERA-2 |
Fogh & Trempe, Human Tumor Cells in Vitro : 115 (1975) |
|
M |
22 |
DSMZ |
| PC-3 |
Metastatic poorly differentiated prostate adenocarcinoma cell line |
Kaighn et al., Invest Urol 17: 16-23 (1979) |
bone marrow |
M |
62 |
DSMZ |
| RT-4 |
Urinary bladder transitional cell carcinoma cell line |
Rigby et al., Br J Cancer 24: 746 (1970) |
urinary bladder |
M |
63 |
DSMZ |
|
|
| Cell line |
Description of cell line |
Original reference |
Origin |
Sex |
Age |
Source |
| A-431 |
Epidermoid carcinoma cell line |
Giard et al., J Natl Cancer Inst 51: 1417 (1973) |
skin |
F |
85 |
DSMZ |
| HaCaT |
Keratinocyte cell line |
Boukamp et al., J Cell Biol Mar 106(3): 761 (1988) |
skin |
M |
0 |
NEF3 |
| SK-MEL-30 |
Metastatic malignant melanoma cell line |
Carey et al., Proc Natl Acad Sci USA 73: 3278 (1976) |
subcutis |
M |
67 |
DSMZ |
| WM-115 |
Malignant melanoma cell line |
Westermark B. et al, Proc Natl Acad Sci U S A. Oct; 83(19): 7197 (1986) |
skin |
F |
58 |
BW2 |
|
|
| Cell line |
Description of cell line |
Original reference |
Origin |
Sex |
Age |
Source |
| RH-30 |
Metastatic rhabdomyosarcoma cell line |
Douglass et al., Cytogenet Cell Genet 45: 148-155 (1987) |
bone marrow |
M |
17 |
DSMZ |
| U-2 OS |
Osteosarcoma cell line |
Ponten J., Saksela E. Int. J. Cancer 2: 434 (1967) |
bone |
F |
15 |
LGC/ATCC |
| U-2197 |
Malignant fibrous histiocytoma cell line |
Genberg et al., Am J Pathol 135: 1185 (1989) |
subcutis |
M |
79 |
DSMZ |
|
|
| Cell line |
Description of cell line |
Original reference |
Origin |
Sex |
Age |
Source |
| BEWO |
Metastatic choriocarcinoma cell line |
Pattillo et al., Cancer Res 28: 1231-1236 (1968) |
brain |
|
0 |
DSMZ |
| HEK 293 |
Embryonal kidney cell line, transformed by adenovirus type 5 |
Graham et al., J Gen Virol 36: 59 (1977) |
embryonal kidney |
|
0 |
DSMZ |
| HTh 83 |
Anaplastic thyroid carcinoma cell line |
Dahlman et al., J. Pathol. 191: 376-386, 2000 |
thyroid |
M |
67 |
NEH4 |
| TIME |
Telomerase-immortalized human microvascular endothelial cells (pooled) |
Venetsanakos et el., Exp Cell Res., Feb 1;273(1): 21-33 (2002) |
skin |
|
0 |
LCW5 |
|
| |
| Cell |
Description of origin |
Sex |
|
| Leukemia, AML |
|
F |
|
| Leukemia, AML |
|
F |
|
| Leukemia, B-ALL |
|
F |
|
| Leukemia, B-CLL subtype 1 |
B-CLL subtype 1 (100) |
M |
|
| Leukemia, B-CLL subtype 2 |
B-CLL subtype 2 (95-98) |
M |
|
| Leukemia, B-CLL subtype 3 |
B-CLL subtype 3 (<95) |
F |
|
| Leukemia, B-CLL subtype 4 |
B-CLL subtype 4 (3-21) |
M |
|
| Leukemia, CML |
|
M |
|
| Leukemia, CML |
|
M |
|
| Leukemia, T-ALL |
|
M |
|
| PBMC |
Peripheral Blood Mononuclear Cells from healthy blood donors |
M |
|
| PBMC |
Peripheral Blood Mononuclear Cells from healthy blood donors |
F |
|